Determining the effect of a dairy product enriched with glucomannan and inulin in type 2 diabetic patients.
- Conditions
- Type 2 diabetes.Diabetes mellitus due to underlying condition
- Registration Number
- IRCT20230704058672N1
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 80
Age range from 20 to 60 years
Body mass index between 25 -35 kg/m2
If taking medication to control blood sugar and lipid profile, a fixed-dose medication during the entire intervention
Desire to cooperate
Participation in weight loss programs during the last 6 months (weight loss less than 10% in the last 6 months)
Change in physical activity during the past 4 weeks
Taking drugs that affect appetite and body weight or have an anti-inflammatory effect.
Taking antioxidants or multivitamins and any type of food supplement in the last 3 months
Pregnancy or breastfeeding
Gastrointestinal surgery or weight loss (bariatric) surgery
Smoking cessation in the last 6 months
Kidney disease
History of recurrent kidney stones
Liver dysfunction
Untreated hypertension
History or symptoms of gallstones
Cancer
History of endocrine disorders (especially hypothyroidism)
History of bulimia and/or laxative abuse
Mental disorders or impaired independence
History of alcohol or other drug abuse
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method